Analyst Ratings for Cellectis (CLLS)
CLLS Rating Summary
CLLS Price Target Summary
- Highest: $9.00 (Barclays)
- Lowest: $7.00 (Jefferies)
- Average: $8.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.25 (+176.8%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Avg. $ Target:
$8.25 (+176.8%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/28/2026 | Barclays | Lukas Shumway | New Coverage | Overweight (N/A) |
9.00 (N/A) |
3.67 (2.98) |
-18.8% | Details |
| 2/17/2026 | Jefferies | Amin Makarem | New Coverage | Buy (N/A) |
7.00 (6.00) |
3.49 (2.98) |
-14.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
